REQUEST A DEMO
Total
USD $0.00
Search more companies

Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Chongqing Pharscin Pharmaceutical Co., Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) is an enterprise located in China, with the main office in Chongqing. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on November 04, 1996. Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) currently employs 1,384 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 1.9% in Q3C2025. A growth of 4.5% was recorded in its total assets. The net profit margin of Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) decreased by 1.29% in 2025.

Headquarters
No. 89, Middle Section of Huangshan Avenue, Yubei District, Chongqing
Chongqing; Chongqing; Postal Code: 401120

Contact Details: Purchase the Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report to view the information.

Website: http://www.pharscin.com

Basic Information
Total Employees:
Purchase the Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report to view the information.
Registered Capital:
Purchase the Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report to view the information.
Incorporation Date:
November 04, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
39.04%
Purchase this report to view the information.
17.34%
Purchase this report to view the information.
8.76%
Purchase this report to view the information.
8.6%
Purchase this report to view the information.
1.41%
Subsidiaries
Beijing Bosen Biotechnology Co., Ltd.
100%
Beijing Huasen Yingnuo Biotechnology Co., Ltd.
100%
Chongqing Huasen Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Chongqing Pharscin Pharmaceutical Co., Ltd. (重庆华森制药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
1.9%
Total Operating Revenue
5.36%
Operating Profit
19.02%
Net Profit/Loss for the Period
-8.93%
Total Assets
4.5%
Total Equity
3.18%
Operating Profit Margin
2.44%
Net Profit Margin
-1.29%
Return on Equity (ROE)
-0.53%
Quick Ratio
-33.42%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?